JF
KRSA

Jump Financial’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Jump Financial’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-371
Closed -$160K – 1445
2021
Q3 		$160K Buy
+371
New +$24.3K 0.01% 915

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jump Financial's KRSA Position: Q4 2021 in Review

Jump Financial sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2021, closing a stake of 371 shares — an estimated $160K sold.

Jump Financial first reported a position in KRSA in Q3 2021 and held it in 1 quarter. The position peaked at $160K in Q3 2021. 51 funds tracked by Wall St. Rank hold KRSA as of Q4 2021.

  • Jump Financial reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Jump Financial sold 371 Korsana Biosciences, Inc. Common Stock shares in Q4 2021, an estimated $160K.
  • Jump Financial first reported a position in Korsana Biosciences, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Jump Financial's Korsana Biosciences, Inc. Common Stock position peaked at $160K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2021.

Based on Jump Financial's 13F filing for Q4 2021, filed 10 Feb 2022.